La thérapie génique : la recherche progresse ! Gene therapy: research is progressing!
Main Article Content
Abstract
Grâce aux progrès réalisés dans le domaine de la biologie cellulaire et moléculaire, les scientifiques ont développé un ensemble de techniques, qui ont permis de manipuler et de réorganiser les gènes de divers organismes vivants, ce qui a abouti à la mise au point de tout un éventail de nouveaux médicaments.
La biotechnologie moderne s’inscrit dans cette stratégie et regroupe le segment des produits issus de l’ADN recombinant (insuline humaine, somatotropine…)
et celui des acides nucléiques qui concerne entre autres la thérapie génique. Le nombre d’essais de thérapie génique approuvés
dans le monde a progressivement augmenté ces dernières années, atteignant 116 protocoles par an en 1999 et un total de 2210 protocoles
approuvés en 2015[1].
Cet article retrace l’intérêt de la thérapie génique et son bénéfice clinique obtenu au cours des dix-sept dernières années.
Downloads
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
A- Open Access statement and license:
1-Open Access statement:
JFMO provides immediate open access to published content in support of the idea that free access to research helps support the dissemination of knowledge and ideas in the field of medical science. All articles will be published under Creative Commons licenses.
All published data is immediate free access to the work and permits any user to read, download, copy, distribute print, search, or link to the full texts of articles.
The users of any published material in the JFMO must act in accordance with the Creative Commons Licenses CC BY-NC-ND 4.0.
2-License:
All published data is distributed following the Creative Commons Licenses CC BY-NC-ND 4.0. This license is allowing others to download the works and share them with others as long as they correctly cite the manuscript, No changes are allowed to the original manuscript and the manuscript must be used only for non for profit or non-commercial purposes.
This work is licensed under a Creative Commons AttributionNonCommercial-NoDerivatives 4.0 International License.
3-Self Archiving:
Authors are permitted and encouraged to share online their articles published in JFMO (e.g., in institutional repositories or on their website), as it can lead to productive exchanges, as well as earlier and greater citation of published work.
